Navigation Links
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Date:10/30/2009

ent adverse events, nausea was reported with the greatest incidence (5 mcg, 3 percent; 10 mcg, 13 percent). Hypoglycemia was reported in 5 percent of patients taking 5 mcg and 4 percent of patients taking 10 mcg, with no severe hypoglycemic events.

In addition to the monotherapy indication, the FDA approved changes to the BYETTA Prescribing Information to incorporate updated safety information, including pancreatitis-related language added to the Warnings and Precautions section. This update addresses the alert issued by the FDA in August 2008. The new label also expands upon existing language regarding use of BYETTA in patients with renal impairment. In addition, the label has been amended to match the format the FDA currently uses for Prescribing Information. This label update is being communicated to physicians via a "Dear Healthcare Professional" letter, which will be available at www.BYETTA.com.

"Patient safety is our foremost concern at Amylin and Lilly, and the BYETTA Prescribing Information represents an important way to communicate the information that healthcare professionals and patients need in order to use the medication safely and effectively," Kolterman continued. "Thus, the updated label offers the most current information about the benefit-risk profile of BYETTA as a foundational therapeutic choice for people with type 2 diabetes."

BYETTA has been used by more than one million patients since market introduction in 2005. It has a proven history with more than 10 million prescriptions written and 6.5 years of clinical experience.

About Diabetes

Diabetes affects more than 24 million people in the United States and an estimated 246 million adults worldwide.(ii,iii) Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes is the fifth leading cause of death by disease in the United States and costs approximately $174 bi
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
2. Surveyed Experts Indicate That Byetta LAR and Victoza Have Advantages Over Actos in the Treatment of Type 2 Diabetes
3. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
4. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
5. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
6. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
7. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
8. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
9. Clexane(R)/Lovenox(R) Approved in Japan
10. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
11. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , BLAUVELT, N.Y., Nov. 19 ...at germ extract, responds to a press release issue...he Hungarian company for making false and self-ser... BioSciences. ,, Dr. Hidvegi stated from his o... claim that research on Avemar does not apply to A...
(Date:11/19/2009)..., , MUNSTER, Germany, November 19 /PR...they have filed on November 16th, 2009 Flibanserin...uced dyskinesia in Parkinson,s,disease for orphan ...s Agency,(EMEA). Levodopa-induced dyskinesia is a ... Parkinson,s and a serious burden to some of those...
(Date:11/19/2009)..., , VIENNA, Austria, November 19 /PR... vaccine program on one product candidate at an un... candidate AD02 is planned to enter into,Phase II ... company,immediately follows the completion of two... The company based its fast decision on the first ...
(Date:11/18/2009)... Scientists at Queen,s University Belfast are deve...llegal drugs which will help in the fight against ...ill use special gel pads to ,swipe, an individual ...alysed by a scanning instrument that can detect th...allow better, faster decisions to be made in respo...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
... I didnt realize the depth of the task in front of... Midwest list of public and private biotech compan..., lets first start with Illinois, which is the cen...imated that there were between 200 and 300 biotech... these being public companies. My guesstimate at t...
...- U.S. Representative Tammy Baldwin and Wisconsin ...nsin companies will each receive federal grants of... and product development efforts. , ,Both based in...StrataGraft" skin tissue that could serve as synth...nologies that use non-flammable, renewable feed st...
...li Lilly & Company recently expressed concern to D...hat the HIPAA privacy rule may impede clinical res...acklogged with requests to review and approve thou...sure of information, according to a letter from St...based Eli Lilly. , ,In a response letter, Richard...
Other Biology Technology:ePrairie Uncovers 80 Biotech Companies in Illinois 2ePrairie Uncovers 80 Biotech Companies in Illinois 3ePrairie Uncovers 80 Biotech Companies in Illinois 4ePrairie Uncovers 80 Biotech Companies in Illinois 5ePrairie Uncovers 80 Biotech Companies in Illinois 6ePrairie Uncovers 80 Biotech Companies in Illinois 7ePrairie Uncovers 80 Biotech Companies in Illinois 8ePrairie Uncovers 80 Biotech Companies in Illinois 9ePrairie Uncovers 80 Biotech Companies in Illinois 10ePrairie Uncovers 80 Biotech Companies in Illinois 11ePrairie Uncovers 80 Biotech Companies in Illinois 12ePrairie Uncovers 80 Biotech Companies in Illinois 13ePrairie Uncovers 80 Biotech Companies in Illinois 14ePrairie Uncovers 80 Biotech Companies in Illinois 15ePrairie Uncovers 80 Biotech Companies in Illinois 16ePrairie Uncovers 80 Biotech Companies in Illinois 17Stratatech and Virent Win $4M in U.S. Grants 2Stratatech and Virent Win $4M in U.S. Grants 3Stratatech and Virent Win $4M in U.S. Grants 4Stratatech and Virent Win $4M in U.S. Grants 5
(Date:11/20/2009)...al molecules like RNA and DNA is how they first ca...ursors. Now, in a study appearing in this week,s J... the earliest evolutionary steps yet: generating l...othing but warm water. , Many researchers belie...les present, before DNA and proteins; however, the...
(Date:11/20/2009)...ess an ingenious mechanism for preventing oxygen f...is the new finding of a team of biologists that in...rch institute in Flanders, Belgium, connected to t... this discovery by modifying the DNA of the intest...s model organism, they have uncovered the existenc...
(Date:11/20/2009)...(ERC) has been awarded a grant from the U.S. Depar...ring and reusing the heat that would be generated ...in a carbon capture system. The goal of the resear...uestration, or storage (CCS), and thus limit the a... atmosphere by coal-fired power plants. , Unlike...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Orlando Regional Medical Center 28ORMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Better Care for Patients with Bloodstream Infections 52229 1Orlando Regional Medical Center 28ORMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Better Care for Patients with Bloodstream Infections 52229 2Orlando Regional Medical Center 28ORMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Better Care for Patients with Bloodstream Infections 52229 3Kashi Company Introduces TLC 28R 29 Dark Mocha Almond Chewy Bar 52224 1Kashi Company Introduces TLC 28R 29 Dark Mocha Almond Chewy Bar 52224 2Novasys Medical Receives 2418 95 Million in Second Tranche of Series D Financing 52219 1Novasys Medical Receives 2418 95 Million in Second Tranche of Series D Financing 52219 2
...e long, thin molecule that carries our hereditary ... in the cell nucleus into tiny spheres called nucl...g the entire chromosome, which is itself folded an...s how, when and where a nucleosome will be positio...earch student Yair Field of the Computer Science a...
...y years, researchers believed that stem cells in t...slumber-like state, unaware of -- and unaffected b... system. , Not so. , Scientists at the Oklahoma M...rrow stem cells -- undifferentiated cells that eve...fection -- possess receptors that recognize bacter...
...in,s septum helps prevent epileptic seizures by in...its of another area of the brain known as the hipp...f Neurophysiology. The researchers found that, by ...ileptic rats, they could reduce epileptic seizures...networks in chronically epileptic rats: Potential ...
Other Biology News:Scientists discover a genetic code for organizing DNA within the nucleus 2Scientists discover a genetic code for organizing DNA within the nucleus 3Can you hear me now? Scientists find previously unknown receptors on adult stem cells 2Septum keeps neurons in synch, can reduce epileptic seizures by 90 percent 2Septum keeps neurons in synch, can reduce epileptic seizures by 90 percent 3
...statistical interpretation to researchers, product...an accepted organizational standard for analytics ...users and includes the comprehensive analytics nee... Language (JSL), a menu generator, and journaling ...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Novus Biologicals
RNAsin from BD Biosciences Pharmingen
Newborn Calf Serum, Heat Inactivated from Sigma-Aldrich
Biology Products: